15 WORLD GASTROENTEROLOGY NEWS JANUARY 2015 Editorial | Expert Point of View | Gastro 2015: AGW/WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events Gut Microbiota is Booming in GI Congress of China Ye Chen, MD, PhD Vice Chairman of the Youth Committee of CSG Division of Gastroenterology Nanfang Hospital of Southern Medical University Guangzhou, China Yunsheng Yang, Professor and MD President of the Chinese Society of Gastroenterology (CSG) Chinese PLA General Hospital Beijing, China The opening of CGC 2014 on November 1st in Chongqing, China. The Congress of Gastroenterology China 2014 (CGC 2014) was hosted by the Chinese Society of Gastroen-terology (CSG) in Chongqing, China from October 31 to November 2. Over 5,000 participants attended the meeting. During this annual national event, the CSG Committee of Gut Microbiota organized a special symposium to cover the important research, progress, and perspective on gut microbiota. Twenty speak-ers from China presented lectures on current highlight topics, such as the bioinformatics for gut microbiota, fermentation of gut microbiota, gut microbiota in gastrointestinal (GI) diseases, the effects of diets, drugs and probiotics on gut microbiota compo-sition, and fecal microbiota transplan-tation (FMT) for inflammatory bowel disease (IBD) and constipation, FMT safety and standardization, etc. Professor Yunsheng Yang, President of the CSG, gave a keynote speech about the strategy and perspective of gut microbiota research in translation and practice. Dr. El-Omar, editor in chief for Gut, introduced the essential abstracts about microbiota from the United European Gastroenterology Week (UEGW) 2014. Dr. Magnus Simrén, Sweden, spoke about intes-tinal microbiota in irritable bowel syndrome (IBS). The attendees par-ticipated in the exciting discussions. A variety of methods have been used as tools for studying gut micro-biota. Bacterial cultures have a lim-ited role in gut microbiota research. Though the 16srRNA sequencing has been widely used for gut microbiota, the exploration of next-generation sequencing technology and the metagenomics was concerned and dis-cussed. Meanwhile, gut fermentation (GT) technology was introduced. As shown in in vitro models, GT can be used for further investigations on gut microbiota. FMT has also been seri-ously concerned and fiercely debated; this traditional Chinese medicine, which can be traced back about 3,000 years, has regained its new vitality. Dr. Yunsheng Yang’s team in Beijing, Dr. Faming Zhang from Nanjing and Dr. Yongzhan Nie from Xi’an, reported their results of FMT treatment on refractory IBD and intractable constipation. They also introduced their experiences of donor screening procedure, stressed FMT safety, and disagreed with Home-FMT without medical monitoring. Through these introductions and group discussions, most of the participants agreed that FMT treatment is generally safe and effective for Clostridium difficile infec-tion (CDI), it may have potential risks (e.g., undetectable/occult patho-gen infections) and undetermined long-term effects. They considered
ewgn-vol19-issue4-FINAL
To see the actual publication please follow the link above